Table 2.
Serum Lipid Levels (mmol/L) | UK Biobank |
European Prospective Investigation into Cancer and Nutrition-Norfolk |
||||
---|---|---|---|---|---|---|
β Coefficient | 95% Confidence Interval | P Value | β Coefficient | 95% Confidence Interval | P Value | |
Total cholesterol per 1-SD increase | 0.09 | 0.06–0.11 | <0.001 | 0.19 | 0.07–0.31 | 0.001 |
Total cholesterol in quartiles | ||||||
1 | Reference | Reference | ||||
2 | 0.15 | 0.09–0.21 | <0.001 | 0.22 | –0.07 to 0.50 | 0.14 |
3 | 0.19 | 0.13–0.25 | <0.001 | 0.16 | –0.15 to 0.47 | 0.32 |
4 | 0.23 | 0.16–0.29 | <0.001 | 0.43 | 0.11–0.75 | 0.008 |
P value for trend | <0.001 | 0.017 | ||||
HDL-C per 1-SD increase | 0.11 | 0.08–0.13 | <0.001 | 0.14 | 0.03–0.25 | 0.016 |
HDL-C in quartiles | ||||||
1 | Ref | Ref | ||||
2 | 0.13 | 0.07–0.19 | <0.001 | 0.12 | –0.15 to 0.39 | 0.39 |
3 | 0.21 | 0.15–0.27 | <0.001 | 0.28 | –0.01 to 0.57 | 0.06 |
4 | 0.30 | 0.23–0.37 | <0.001 | 0.27 | –0.04 to 0.58 | 0.09 |
P for trend | <0.001 | 0.06 | ||||
LDL-C per 1-SD increase | 0.07 | 0.05–0.09 | <0.001 | 0.17 | 0.06–0.29 | 0.003 |
LDL-C in quartiles | ||||||
1 | Ref | Ref | ||||
2 | 0.08 | 0.02–0.14 | 0.009 | 0.09 | –0.19 to 0.37 | 0.53 |
3 | 0.11 | 0.05–0.18 | <0.001 | 0.13 | –0.17 to 0.43 | 0.40 |
4 | 0.18 | 0.12–0.24 | <0.001 | 0.48 | 0.15–0.81 | 0.004 |
P value for trend | <0.001 | 0.007 | ||||
Triglycerides per 1-SD increase | –0.05 | –0.08 to –0.03 | <0.001 | –0.05 | –0.15 to 0.05 | 0.30 |
Triglycerides in quartiles | ||||||
1 | Ref | Ref | ||||
2 | 0.01 | –0.05 to 0.07 | 0.69 | 0.04 | –0.23 to 0.31 | 0.78 |
3 | –0.04 | –0.09 to 0.02 | 0.22 | 0.02 | –0.25 to 0.28 | 0.90 |
4 | –0.12 | –0.18 to –0.06 | <0.001 | –0.10 | –0.38 to 0.18 | 0.48 |
P value for trend | <0.001 | 0.49 | ||||
Apolipoproteins per 1-SD increase (g/dl) | ||||||
A | 0.11 | 0.09–0.13 | <0.001 | — | — | — |
B | 0.08 | 0.05–0.10 | <0.001 | — | — | — |
Cholesterol components in same model per 1-SD increase | ||||||
HDL-C∗ | 0.10 | 0.08–0.13 | <0.001 | 0.13 | 0.02–0.24 | 0.019 |
LDL-C† | 0.07 | 0.05–0.09 | <0.001 | 0.17 | 0.05–0.28 | 0.004 |
Serum lipids in same model | ||||||
TC‡ | 0.11 | 0.08–0.13 | <0.001 | 0.22 | 0.10–0.34 | <0.001 |
Triglycerides§ | –0.09 | –0.11 to –0.07 | <0.001 | –0.09 | –0.20 to 0.01 | 0.065 |
Clinical serum lipid ratios | ||||||
TC to HDL-C | –0.03 | –0.05 to –0.01 | 0.005 | –0.01 | –0.11 to 0.09 | 0.861 |
LDL-C/HDL-C | –0.02 | –0.05 to –0.00 | 0.046 | 0.03 | –0.07 to 0.14 | 0.541 |
Triglycerides to HDL-C | –0.08 | –0.10 to –0.06 | <0.001 | –0.10 | –0.20 to 0.01 | 0.055 |
HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; SD = standard deviation; TC = total cholesterol.
All analyses are adjusted for age, sex, ethnicity, Townsend deprivation index, body mass index, systolic blood pressure, height, smoking, alcohol status, diabetes status, statin use, oral β-blocker use, and spherical equivalent. Quartiles in UK Biobank are defined as follows: (1) total cholesterol: quartile 1, ≤ 4.88; quartile 2, 4.89–5.62; quartile 3, 5.63–6.39; and quartile 4, ≥ 6.40; (2) HDL-C, quartile 1, ≤ 1.18; quartile 2, 1.19–1.41; quartile 3, 1.42–1.69; and quartile 4, ≥ 1.70; (3) LDL-C: quartile 1, ≤ 2.92; quartile 2, 2.93–3.48; quartile 3, 3.49–4.08; and quartile 4, ≥ 4.09; and (4) triglycerides: quartile 1, ≤ 1.02; quartile 2, 1.03–1.44; quartile 3, 1.45–2.07; and quartile 4, ≥ 2.08. Quartiles in EPIC-Norfolk are defined as follows: (1) TC: quartile 1, ≤ 4.67; quartile 2, 4.68–5.49; quartile 3, 5.50–6.19; and quartile 4, ≥ 6.20–10.20; (2) HDL-C: quartile 1, ≤ 1.21; quartile 2, 1.22–1.46; quartile 3, 1.47–1.77; and quartile 4, ≥ 1.78; (3) LDL-C: quartile 1, ≤ 2.46; quartile 2, 2.47–3.14; quartile 3, 3.15–3.83; and quartile 4, ≥ 3.84; and (4) triglycerides: quartile 1, ≤ 1.19; quartile 2, 1.20–1.57; quartile 3, 1.58–2.19; and quartile 4, ≥ 2.20.
Additionally adjusted for LDL-C.
Additionally adjusted for HDL-C.
Additionally adjusted for triglycerides.
Additionally adjusted for TC.